About 1,500 confirmed cases of monkey pox have been identified in 25 European countries, accounting for about 85% of all diagnoses worldwide.
Through the Emergency Preparedness and Response Authority – HERA, the EU has entered into a contract with Bavarian Nordic to purchase 109,090 doses of the 3rd generation vaccine in response to the ongoing monkeypox epidemic.
The supply of the Member States will start by the end of this month and priority will be given to the countries with the greatest needs.
The European Union is using for the first time funds through the EU4Health program for the direct purchase of vaccines and the supply of its Member States.
This vaccine is approved for smallpox in Europe, but is just as effective for monkeypox.
The EU’s response to this monkey pox epidemic proves that with concerted action EU Member States can achieve much better results.
Source: Capital
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
.jpeg "Nature holidays: on a sailing boat to the Pontine Islands with WWF experts")
.jpg "Megan Fox and “compartmentalization”, the self-defense mechanism that was triggered after suffering violence")
